Index
Pagenumbersfollowedby“f”indicatefigures,“t”indicatetables,and“b”
indicateboxes.
A
Abciximab,forKawasakisyndrome,991
Abdominalaorta,echocardiographicquantificationandidentificationofpatterns
offlowin,303,303f
Abernethymalformation,471,472f
Ablation,catheter
electrophysiologyand,360–364,363f
forsupraventriculartachycardia,345–346
ABO-incompatibletransplantation,1222f,1226
Absorbablesutures,220
Absorption,1429
Acceleratedidioventricularrhythm,350
Accuracy,ofdata,410
ACEIs,Angiotensinconvertingenzymeinhibitors
Acetaminophen
forhemodynamicallysignificantarterialduct,199
forKawasakisyndrome,992
ACHD,Adultcongenitalheartdisease
Acid-basemanagement,incardiopulmonarybypass,229
Acidlipasedeficiency,cardiacinvolvementin,1093
Acidemia
methylmalonic,cardiacinvolvementin,1097
propionic,cardiacinvolvementin,1097
Acousticshadowing,onultrasoundimages,283
Acquiredcardiacdisease
healthsystemchallengesin,1522–1523
pharmacogeneticsintreatmentof,duringchildhood,1429–1440
dose-exposure-responserelationship,1430,1431f,1432t
ventriculoarterialinteractionin,1377–1379
Acromegaly,cardiacinvolvementin,1096
Actin,incardiomyocyte,72–73
Activityrestrictions,forcancertherapy-relatedcardiotoxicity,1172
Acutecardiorenalsyndrome,interventionsof,1422–1425,1424t–1425t
Acutecirculatoryfailure,1179–1191
backgroundof,1179–1180
cardiovasculardrugsfor,1183–1185,1184t
clinicalmanifestationsof,1180,1180t
diagnosisof,1180–1181
earlyrecognitionof,1181
epidemiologyof,1179
investigationof,1181
laboratorystudiesof,1181
managementof,1181–1182
monitoringof,1181
near-infraredspectroscopyin,1181
pathophysiologyof,1179–1180
pulmonaryarterycatheterizationin,1181
pulseindexcontinuouscardiacoutputin,1181
temporaryextracorporeallifesupportfor,1185–1191
therapeutictargetsfor,1182
therapeutictoolsfor,1182
ventilationfor,1182–1183
Acutedecompensatedheartfailure(ADHF),1426
Acutedecompensation,managementof,inFontanpathway,1292–1293
Acutedeterioration,managementof,inFontanpathway,1293–1294
Acutekidneydisease(AKI)
associatedwithcardiacsurgery,1421–1422,1423t
cardiacsurgeryassociated
long-termrenalconsequencesof,1425,1425t
Acutekidneyinjury,inFontanpathway,1295
Acutemyocardialdysfunction,withreducedcardiacoutputandincreased
afterload,1179
Acutepostoperativepulmonaryhypertension,1384–1385,1384f–1385f
Acutepulmonaryhypertension,inprematurity,205
Acuterenalconsequences,ofcardiacdiseaseinchildren,1421–1427
cardiorenalsyndromes,classificationof,1421–1427,1422t
Acuterespiratoryfailureafterextubation,managementof,inFontanpathway,
1294–1295
Acuterheumaticfever(ARF),997–1021,1023
cellularresponseand,1002
clinicalmanifestationsof,1004–1007,1006f,1006t
carditis,1007–1009,1007b
erythemamarginatum,1010–1011,1011f
minor,1011
polyarthritis,1009
subcutaneousnodules,1010,1010f–1011f
Sydenhamchorea,1009–1010
valvitis,subclinical,1008–1009,1008b
diagnosisof,difficultieswith,1011–1012
epidemiologyof,998–999,999f
etiologyandpathogenesisof,999–1000
historicalbackgroundof,997–998
humanleukocyteantigenassociatedwith,1001,1001t
humoralresponseand,1001–1002,1002f
interactionbetweenhostandpathogensin,1001
laboratoryinvestigationsin,1012–1015
acute-phasereactantsin,1013